KODIAK SCIENCES INC. 5,193,237 Shares of Common Stock, par value $0.0001 per share Underwriting AgreementKodiak Sciences Inc. • November 18th, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledNovember 18th, 2020 Industry JurisdictionKodiak Sciences Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 5,193,237 shares of common stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 778,985 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.